Literature DB >> 4167273

Changes in blood-volume produced by treatment in the nephrotic syndrome.

E S Garnett, C E Webber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4167273     DOI： 10.1016/s0140-6736(67)92234-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Spontaneous femoral artery thrombosis and intermittent claudication in childhood nephrotic syndrome.

Authors:  B M Harrison; C B Wood
Journal:  Arch Dis Child       Date:  1972-10       Impact factor: 3.791

2.  Children referred for acute dialysis.

Authors:  S R Meadow; J S Cameron; C S Ogg; H M Saxton
Journal:  Arch Dis Child       Date:  1971-04       Impact factor: 3.791

Review 3.  Intra- and extrarenal factors of oedema formation in the nephrotic syndrome.

Authors:  T Tulassay; W Rascher; K Schärer
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

4.  Gross oedema in the nephrotic syndrome treated with frusemide in high dosage.

Authors:  P D Snashall
Journal:  Br Med J       Date:  1971-02-06

5.  Salt-poor human albumin in management of nephrotic syndrome.

Authors:  A M Davison; A T Lambie; A H Verth; J D Cash
Journal:  Br Med J       Date:  1974-03-16

6.  A study of the renin-angiotensin system and the blood volume in the nephrotic syndrome.

Authors:  H D Yoo; K S Choi; M H Jung; W S Lee; J W Lee; S R Lee; J S Kim; W K Cho
Journal:  Korean J Intern Med       Date:  1986-01       Impact factor: 2.884
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.